What does the evidence say about Pomegranate Cardiovascular Meta-Analysis?

The current Migaku evidence database contains 2 reusable source documents for Pomegranate Cardiovascular Meta-Analysis. This answer focuses on benefits, uncertainty, and practical interpretation. - Results PJ consumption was associated with significant reductions in TG (MD: -8.2 mg/dL) and LDL-C (MD: -4.8 mg/dL), and a significant increase in HDL-C (MD: +2.8 mg/dL). [Ghaemi F (2026); evidence level 1] - Conclusion PJ may improve lipid profiles, particularly by reducing TG and LDL-C and increasing HDL-C levels. [Ghaemi F (2026); evidence level 1] - Objective Pomegranate juice (PJ) is rich in polyphenols with potential lipid-lowering effects. [Ghaemi F (2026); evidence level 1] - This study aimed to evaluate the impact of PJ consumption on blood lipid parameters through a systematic review and meta-analysis of randomized controlled trials (RCTs). [Ghaemi F (2026); evidence level 1] - Pomegranates are fruits with a high phenol content that have an antihypertensive effect. [Betanzos-Cabrera G (2026); evidence level 2] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.